Search Results
ASCO 2018: Dr. Birrer on Practice-Changing Ovarian Cancer Studies
Gynaecology highlights from ASCO 2018
Dr. Birrer on the Approval Process in Ovarian Cancer
Gynecologic Oncology at ASCO 2018: Ovarian cancer, JCOG0602, Onda
Dr. Michael Birrer on Bevacizumab in Ovarian Cancers
ASCO 2018: Dr. Westin Sheds Light on PARP Inhibitor Abstracts in Ovarian Cancer
ASCO 2018: Dr. Coleman Shares Insight on Ongoing Research in Ovarian Cancer
Dr. Birrer on Other Targets in Ovarian Cancer
Gynecologic Oncology at ASCO 2018: Ovarian cancer, MITO16B-MaNGO OV2B-ENGOT OV17, Pignata
Michael Birrer Discusses Personalization of Ovarian Cancer Care
Michael J. Birrer MD, PhD: Future of Ovarian Cancer Treatment: Personalized Medicine
Society of Gynecologic Oncology 50th Anniversary: Michael Birrer, MD, PhD
